RIBEF Ibero American Network of Pharmacogenetics & Pharmacogenomics.
IPN Instituto Politécnico Nacional CIIDIR-Unidad Durango, Mexico.
Pharmacogenomics. 2023 Jun;24(9):489-492. doi: 10.2217/pgs-2023-0098. Epub 2023 Aug 2.
The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it has studied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations' was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17 years of uninterrupted work by RIBEF, the Declaration of Mérida/T'Hó and the call for the Dr José María Cantú Award for studies focused on the pharmacogenetics of native populations in Latin America were presented.
伊比利亚美洲遗传药理学和遗传基因组学网络（RIBEF）研究拉丁美洲人群，以从实施个性化医疗中受益。自 2006 年以来，它一直研究种族，以便在拉丁美洲的本土人群中应用遗传药理学知识，同时考虑到祖传医学。在墨西哥城举行了“遗传药理学：拉丁美洲人群的种族、治疗和健康”会议，介绍了 RIBEF 与拉丁美洲研究人员以及墨西哥、西班牙和埃斯特雷马杜拉自治区政府合作的重要性。会议展示了 RIBEF 17 年来不间断工作的成果、《梅里达宣言/T'Hó》以及呼吁设立何塞·马利亚·坎图博士奖，以鼓励对拉丁美洲本土人群的药物遗传学研究。
